A Phase 3, Randomized, Double-Blinded Study to Evaluate the Efficacy and Safety of Once Daily 0.3% Tacrolimus Gel versus Gel Vehicle in the Treatment of Psoriasi

s 1% effort 10 subjects

Awarded By

  • Fujisawa

Contributors

Amount

  • $74,812.00

Start/End

  • December 1, 2004 - December 31, 2005